The significance of therapeutic drug monitoring in detecting low medication adherence in patients with cancer: A case study of cabozantinib
Maintaining good medication adherence is important for providing desirable outcomes from medication therapy. We showed that therapeutic drug monitoring (TDM) contributed to the identification of low medication adherence to cabozantinib in a patient with cancer. We present an educational case to assist with understanding TDM in a patient with cancer.
Authors
- Kenji Momo (ORCID: https://orcid.org/0000-0001-9856-0097)
- Tadatsugu Anno
- Masaru Kato (ORCID: https://orcid.org/0000-0002-6627-1773)
- Hiroshi Kanno (ORCID: https://orcid.org/0000-0003-3340-9462)
- Masaru Ishida
- S. Maruyama (ORCID: https://orcid.org/0009-0008-1386-8112)
Institutions
- SHOWA Medical University (JP)
- SHOWA Medical University Hospital (JP)
Publication Details
- Journal
- Clinical Case Reports
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1002/ccr3.9462
- Citations
- 1
- Primary Topic
- Chronic Myeloid Leukemia Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.45
Funders
- Japan Society for the Promotion of Science